Selection of drug‐resistant HIV‐1 during the early phase of viral decay is uncommon in treatment‐naïve patients initiated on a three‐ or four‐drug antiretroviral regimen including lamivudine期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Selection of drug‐resistant HIV‐1 during the early phase of viral decay is uncommon in treatment‐naïve patients initiated on a three‐ or four‐drug antiretroviral regimen including lamivudine

Authors:	Tobias Bergroth Halime Ekici Magnus Gissln Sabine Kinloch‐de Loes Li‐Ean Goh Andrew Freedman Fiona Lampe Margaret A Johnson Anders Snnerborg

Institution:	1. Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;2. Department of Infectious Diseases, The Sahlgrenska Academy at G?teborg University, G?teborg, Sweden;3. The Royal Free Centre for HIV Medicine, Division of Infection and Immunity, Royal Free Hospital, London, United Kingdom;4. Infectious Diseases MDC, GlaxoSmithKline Research and Development, Greenford, Middlesex, United Kingdom;5. Cardiff University School of Medicine, Cardiff, Wales, United Kingdom;6. Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom;7. Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Abstract:

Keywords:	HIV‐1 minor populations antiretroviral treatment resistance selective real‐time PCR M184I/V